The Voigt Group and PHOENIX Pharma Switzerland have decided to bring their subsidiaries Voigt and Voigt Industrie Service and Amedis-UE respectively into a 50/50 joint venture. After receiving clearance from the Swiss Competition Commission, this closing marks the start of the joint future of Amedis-UE, Voigt Pharma Grosshandel and Voigt Industrie Service under the umbrella of […]
Last night, the city of Zurich played host to the 6th edition of the Legalcommunity Awards Switzerland. The prestigious event saw the recognition and celebration of both in-house counsel and private practice lawyers for their
The Lausanne-based web & mobile digital innovation agency Apptitude has successfully completed a Management Buy Out. Co-founder Axel Pasqualini withdrew after 10 years of growing the business and handed over the lead to Mikhael Minisini and
The Gassmann Group is expanding its shareholding. Fredy Bayard has sold half of its capital to Bernese entrepreneur Stefan Niedermaier. The Groupe is thus underlining its long-term goal of remaining an independent media company anchored
The Farner group, a portfolio company of Waterland Private Equity, partnered with The Skills Group to expand its agency alliance “Team Farner”. The deal, which is its fourth this year, means Farner is now the
The Swiss Financial Market Supervisory Authority FINMA approved the application of Trident Trust as trustee under the Financial Institutions Act (FINIA). Trident Trust Group was founded in 1978 and is a leading independent provider of corporate,
Mosanna Therapeutics, a Basel-based biotechnology company developing the highly differentiated small molecule MOS118 for the treatment of metabolic obstructive sleep apnea, has closed an extension of the Seed Financing Round with the investors Supermoon Capital,
Kellerhals Carrard has advised ETH Zurich spin-off OPTIML, a fast-growing AI startup focused on revolutionizing sustainable real estate, in its successful pre-seed round. The round was co-led by Innovation Endeavors and Planet A Ventures with
ATANIS Biotech, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase. iXLife, a French venture capital fund, co-led the round with US-based AllerFund, the first and
Distalmotion, an international medical device company based in Lausanne, successfully closed the first tranche of its USD 150 million Series F financing round led by Revival Healthcare Capital. Founded and based in Lausanne, Distalmotion has the
